Antibody Targeted PET Imaging of
Animals
Azides
/ chemistry
Carcinoembryonic Antigen
/ metabolism
Cell Line, Tumor
Copper Radioisotopes
Female
Heterocyclic Compounds, 1-Ring
/ chemistry
Immunoconjugates
/ chemistry
Mammary Neoplasms, Experimental
/ diagnostic imaging
Mice
Nanostructures
/ chemistry
Phospholipids
/ chemistry
Polyethylene Glycols
/ chemistry
Positron-Emission Tomography
/ methods
Journal
Bioconjugate chemistry
ISSN: 1520-4812
Titre abrégé: Bioconjug Chem
Pays: United States
ID NLM: 9010319
Informations de publication
Date de publication:
18 03 2020
18 03 2020
Historique:
pubmed:
22
1
2020
medline:
12
2
2021
entrez:
22
1
2020
Statut:
ppublish
Résumé
Lipid nanodiscs (LNDs), comprising a phospholipid bilayer encircled by two molecules of a recombinant membrane scaffold protein, can be targeted to tumors with covalently attached antibodies (Abs) or their fragments. Antibody attachment to click chemistry based PEGylated lipids on LNDs including DOTA allowed PET imaging with the positron emitter
Identifiants
pubmed: 31961138
doi: 10.1021/acs.bioconjchem.9b00854
pmc: PMC8818266
mid: NIHMS1772722
doi:
Substances chimiques
Azides
0
Carcinoembryonic Antigen
0
Copper Radioisotopes
0
Copper-64
0
Heterocyclic Compounds, 1-Ring
0
Immunoconjugates
0
Phospholipids
0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
1HTE449DGZ
Polyethylene Glycols
3WJQ0SDW1A
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
743-753Subventions
Organisme : NCI NIH HHS
ID : P30 CA033572
Pays : United States
Références
FEBS Lett. 1997 Aug 11;413(1):177-80
pubmed: 9287139
Mol Pharm. 2017 May 1;14(5):1623-1633
pubmed: 28294622
FEBS Lett. 2010 May 3;584(9):1721-7
pubmed: 19836392
Nanoscale. 2014 Mar 7;6(5):2782-92
pubmed: 24463404
Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-80
pubmed: 20402623
J Nucl Med. 2003 Dec;44(12):1962-9
pubmed: 14660722
PLoS One. 2014 Sep 16;9(9):e106921
pubmed: 25226518
Bioconjug Chem. 2008 Jan;19(1):89-96
pubmed: 17988078
Int J Nanomedicine. 2016 Jul 05;11:3077-86
pubmed: 27462152
Bioconjug Chem. 2017 Jun 21;28(6):1777-1790
pubmed: 28520406
Pharm Res. 2010 Feb;27(2):361-70
pubmed: 20033475
Nat Rev Drug Discov. 2014 Jun;13(6):445-64
pubmed: 24854407
Annu Rev Med. 2013;64:15-29
pubmed: 23043493
Science. 1982 Mar 19;215(4539):1511-3
pubmed: 7199757
Nat Rev Drug Discov. 2013 Apr;12(4):259-60
pubmed: 23535930
Nat Rev Cancer. 2015 Jun;15(6):347-60
pubmed: 25998714
Cancer. 1994 Sep 1;74(5):1575-83
pubmed: 7914825
Methods Enzymol. 2017;594:1-30
pubmed: 28779836
Bioconjug Chem. 2001 Mar-Apr;12(2):320-4
pubmed: 11312695
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6725-30
pubmed: 11997441
Methods Mol Biol. 2010;624:25-37
pubmed: 20217587
Cancer Biother Radiopharm. 2017 Sep;32(7):247-257
pubmed: 28910151
PLoS One. 2015 Jul 01;10(7):e0129310
pubmed: 26132074
Mol Pharm. 2010 Jun 7;7(3):914-20
pubmed: 20394436
Nat Protoc. 2018 Jan;13(1):79-98
pubmed: 29215632
J Nucl Med. 2014 Jan;55(1):23-9
pubmed: 24337604
Nucl Med Biol. 2017 Apr;47:62-68
pubmed: 28126683
Cancer Res. 1998 Apr 1;58(7):1469-77
pubmed: 9537250
Nature. 2017 Mar 29;543(7647):743-746
pubmed: 28358075
Colorectal Dis. 2012 Sep;14(9):e510-20
pubmed: 22564278